155 related articles for article (PubMed ID: 25778750)
1. Cannabis Use and Reduced Risk of Insulin Resistance in HIV-HCV Infected Patients: A Longitudinal Analysis (ANRS CO13 HEPAVIH).
Carrieri MP; Serfaty L; Vilotitch A; Winnock M; Poizot-Martin I; Loko MA; Lions C; Lascoux-Combe C; Roux P; Salmon-Ceron D; Spire B; Dabis F;
Clin Infect Dis; 2015 Jul; 61(1):40-8. PubMed ID: 25778750
[TBL] [Abstract][Full Text] [Related]
2. Daily cannabis and reduced risk of steatosis in human immunodeficiency virus and hepatitis C virus-co-infected patients (ANRS CO13-HEPAVIH).
Nordmann S; Vilotitch A; Roux P; Esterle L; Spire B; Marcellin F; Salmon-Ceron D; Dabis F; Chas J; Rey D; Wittkop L; Sogni P; Carrieri P;
J Viral Hepat; 2018 Feb; 25(2):171-179. PubMed ID: 28984055
[TBL] [Abstract][Full Text] [Related]
3. No significant effect of cannabis use on the count and percentage of circulating CD4 T-cells in HIV-HCV co-infected patients (ANRS CO13-HEPAVIH French cohort).
Marcellin F; Lions C; Rosenthal E; Roux P; Sogni P; Wittkop L; Protopopescu C; Spire B; Salmon-Ceron D; Dabis F; Carrieri MP;
Drug Alcohol Rev; 2017 Mar; 36(2):227-238. PubMed ID: 27073179
[TBL] [Abstract][Full Text] [Related]
4. Cannabis use and reduced risk of elevated fatty liver index in HIV-HCV co-infected patients: a longitudinal analysis (ANRS CO13 HEPAVIH).
Barré T; Rojas Rojas T; Lacombe K; Protopopescu C; Poizot-Martin I; Nishimwe ML; Zucman D; Esterle L; Billaud E; Aumaitre H; Bouchaud O; Rey D; Piroth L; Salmon-Ceron D; Wittkop L; Sogni P; Carrieri MP; Serfaty L; Marcellin F
Expert Rev Anti Infect Ther; 2021 Sep; 19(9):1147-1156. PubMed ID: 33538612
[No Abstract] [Full Text] [Related]
5. Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users.
Roux P; Fugon L; Winnock M; Salmon-Céron D; Lacombe K; Sogni P; Spire B; Dabis F; Carrieri MP;
Addiction; 2012 Jan; 107(1):152-9. PubMed ID: 21819472
[TBL] [Abstract][Full Text] [Related]
6. Sleep disturbances in HIV-HCV coinfected patients: indications for clinical management in the HCV cure era (ANRS CO13 HEPAVIH cohort).
Costa M; Rojas TR; Lacoste D; Villes V; Aumaitre H; Protopopescu C; Yaya I; Wittkop L; Krause J; Salmon-Céron D; Marcellin F; Sogni P; Carrieri MP;
Eur J Gastroenterol Hepatol; 2019 Dec; 31(12):1508-1517. PubMed ID: 31094856
[TBL] [Abstract][Full Text] [Related]
7. Insulin resistance is associated with a higher risk of hepatocellular carcinoma in cirrhotic HIV/HCV-co-infected patients: results from ANRS CO13 HEPAVIH.
Salmon D; Bani-Sadr F; Loko MA; Stitou H; Gervais A; Durant J; Rosenthal E; Quertainmont Y; Barange K; Vittecoq D; Shoai-Tehrani M; Alvarez M; Winnock M; Trinchet JC; Dabis F; Sogni P
J Hepatol; 2012 Apr; 56(4):862-8. PubMed ID: 22173166
[TBL] [Abstract][Full Text] [Related]
8. Association between elevated coffee consumption and daily chocolate intake with normal liver enzymes in HIV-HCV infected individuals: results from the ANRS CO13 HEPAVIH cohort study.
Carrieri MP; Lions C; Sogni P; Winnock M; Roux P; Mora M; Bonnard P; Salmon D; Dabis F; Spire B;
J Hepatol; 2014 Jan; 60(1):46-53. PubMed ID: 23978720
[TBL] [Abstract][Full Text] [Related]
9. Significant reductions in alcohol use after hepatitis C treatment: results from the ANRS CO13-HEPAVIH cohort.
Knight R; Roux P; Vilotitch A; Marcellin F; Rosenthal E; Esterle L; Boué F; Rey D; Piroth L; Dominguez S; Sogni P; Salmon-Ceron D; Spire B; Carrieri MP;
Addiction; 2017 Sep; 112(9):1669-1679. PubMed ID: 28430385
[TBL] [Abstract][Full Text] [Related]
10. Insulin resistance is associated with progression to hepatic fibrosis in a cohort of HIV/hepatitis C virus-coinfected patients.
Hull MW; Rollet K; Moodie EE; Walmsley S; Cox J; Potter M; Cooper C; Pick N; Saeed S; Klein MB;
AIDS; 2012 Sep; 26(14):1789-94. PubMed ID: 22739388
[TBL] [Abstract][Full Text] [Related]
11. Impact of Alcohol and Coffee Intake on the Risk of Advanced Liver Fibrosis: A Longitudinal Analysis in HIV-HCV Coinfected Patients (ANRS HEPAVIH CO-13 Cohort).
Yaya I; Marcellin F; Costa M; Morlat P; Protopopescu C; Pialoux G; Santos ME; Wittkop L; Esterle L; Gervais A; Sogni P; Salmon-Ceron D; Carrieri MP;
Nutrients; 2018 May; 10(6):. PubMed ID: 29857547
[TBL] [Abstract][Full Text] [Related]
12. Psychiatric and substance use disorders in HIV/hepatitis C virus (HCV)-coinfected patients: does HCV clearance matter? [Agence Nationale de Recherche sur le SIDA et les Hépatites Virales (ANRS) HEPAVIH CO13 cohort].
Michel L; Lions C; Winnock M; Lang JP; Loko MA; Rosenthal E; Marchou B; Valantin MA; Morlat P; Roux P; Sogni P; Spire B; Poizot-Martin I; Lacombe K; Lascoux-Combe C; Duvivier C; Neau D; Dabis F; Salmon-Ceron D; Carrieri MP;
HIV Med; 2016 Nov; 17(10):758-765. PubMed ID: 27187027
[TBL] [Abstract][Full Text] [Related]
13. The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): early findings, 2006-2010.
Loko MA; Salmon D; Carrieri P; Winnock M; Mora M; Merchadou L; Gillet S; Pambrun E; Delaune J; Valantin MA; Poizot-Martin I; Neau D; Bonnard P; Rosenthal E; Barange K; Morlat P; Lacombe K; Gervais A; Rouges F; See AB; Lascoux-Combe C; Vittecoq D; Goujard C; Duvivier C; Spire B; Izopet J; Sogni P; Serfaty L; Benhamou Y; Bani-Sadr F; Dabis F;
BMC Infect Dis; 2010 Oct; 10():303. PubMed ID: 20969743
[TBL] [Abstract][Full Text] [Related]
14. Insulin resistance is not associated with liver fibrosis progression in HIV/hepatitis C virus-coinfected patients.
Merchante N; Macías J; Ramayo E; Vergara S; García-García JA; Mira JA; Corzo JE; Gómez-Mateos JM; Lozano F; Pineda JA
J Viral Hepat; 2006 Jul; 13(7):449-56. PubMed ID: 16792538
[TBL] [Abstract][Full Text] [Related]
15. Influence of insulin resistance on hepatic fibrosis and steatosis in hepatitis C virus (HCV) mono-infected compared with HIV-HCV co-infected patients.
Halfon P; Pénaranda G; Carrat F; Bedossa P; Bourlière M; Ouzan D; Renou C; Tran A; Rosenthal E; Wartelle C; Delasalle P; Cacoub P
Aliment Pharmacol Ther; 2009 Jul; 30(1):61-70. PubMed ID: 19292832
[TBL] [Abstract][Full Text] [Related]
16. SLC30A8 rs13266634 polymorphism is related to a favorable cardiometabolic lipid profile in HIV/hepatitis C virus-coinfected patients.
Pineda-Tenor D; Micheloud D; Berenguer J; Jiménez-Sousa MA; Fernández-Rodríguez A; García-Broncano P; Guzmán-Fulgencio M; Diez C; Bellón JM; Carrero A; Aldámiz-Echevarria T; García-Álvarez M; Resino S
AIDS; 2014 Jun; 28(9):1325-32. PubMed ID: 24499956
[TBL] [Abstract][Full Text] [Related]
17. HCV cure: an appropriate moment to reduce cannabis use in people living with HIV? (ANRS CO13 HEPAVIH data).
Barré T; Mercié P; Lions C; Miailhes P; Zucman D; Aumaître H; Esterle L; Sogni P; Carrieri P; Salmon-Céron D; Marcellin F;
AIDS Res Ther; 2022 Mar; 19(1):15. PubMed ID: 35292069
[TBL] [Abstract][Full Text] [Related]
18. Higher CD163 levels are associated with insulin resistance in hepatitis C virus-infected and HIV-infected adults.
Reid M; Ma Y; Scherzer R; Price JC; French AL; Plankey MW; Grunfeld C; Tien PC
AIDS; 2017 Jan; 31(3):385-393. PubMed ID: 28081037
[TBL] [Abstract][Full Text] [Related]
19. HCV-Related Mortality Among HIV/HCV Co-infected Patients: The Importance of Behaviors in the HCV Cure Era (ANRS CO13 HEPAVIH Cohort).
Santos ME; Protopopescu C; Sogni P; Yaya I; Piroth L; Bailly F; Marcellin F; Esterle L; Wittkop L; Rosenthal E; Morlat P; Roux P; de Araujo WN; Salmon-Ceron D; Carrieri MP;
AIDS Behav; 2020 Apr; 24(4):1069-1084. PubMed ID: 31286317
[TBL] [Abstract][Full Text] [Related]
20. Role of treatment for depressive symptoms in relieving the impact of fatigue in HIV-HCV co-infected patients: ANRS Co13 Hepavih, France, 2006-2008.
Michel L; Villes V; Dabis F; Spire B; Winnock M; Loko MA; Poizot-Martin I; Valantin MA; Bonnard P; Salmon-Céron D; Carrieri MP;
J Viral Hepat; 2010 Sep; 17(9):650-60. PubMed ID: 20002565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]